Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

Biomedicines · 2023 · PMC10295644 · PMID 37371648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

A numerical trend was seen for higher albumin levels at vedolizumab LOR among patients undergoing subsequent medical (median 4.1, IQR 3.9–4.4 g/dl) compared to subsequent surgical therapy (median 3.9, IQR 3.17–4.1 g/dl, p = 0.24).

also in 337 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.